Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on August 7, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

PRISM Pooled Cancer Cell Line Assay Execution

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The contract calls for the execution of a 5-day Luminex-format viability assay using the PRISM platform to evaluate a compound’s effect across approximately 900 barcoded cancer cell lines. The assay will utilize an 8-point, 3-fold dilution series to generate dose-response data, enabling precise measurement of cellular viability under varying concentrations of the compound. All work must be conducted with high technical rigor to ensure the generation of high-quality, reproducible viability data suitable for downstream analysis. The deliverables include comprehensive viability profiles for each cell line and detailed correlation analyses that link compound sensitivity to cellular and genetic characteristics across the panel. The project is structured as a subcontract under the National Institutes of Health, part of the Department of Health and Human Services, with the North American Industry Classification System code 541715 indicating it falls under research and development in the physical, engineering, and life sciences. The solicitation was posted on August 7, 2026, and responses are due by August 24, 2026.

General Info

5-day Luminex assay on 900 cell lines with 8-point dilution series for viability and genetic correlation data.

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

MD

Set-Aside

NONE

Documents

This scope was carved out of 75N98026Q00991.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Library of Pharmacologically Active Compounds (LOP

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Conduct a 5-day Luminex-format viability assay using the PRISM platform to test a compound across ~900 barcoded cancer cell lines with an 8-point, 3-fold dilution series and deliver high-quality viability data and correlation analyses.

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS